Retrospective Cohort Study on the Impact of Travel Distance on Late-Stage Oral Cancer Treatment and Outcomes: An NCDB Analysis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Aug 10

PMID 39123477

Authors

Courtney S Harris

Adrienne Groman

S Lynn Sigurdson

William J Magner

Anurag K Singh

Vishal Gupta

Affiliations

Soon will be listed here.

Abstract

The National Comprehensive Cancer Network guidelines provide evidence-based consensus for optimal individual site- and stage-specific treatments. This is a cohort study of 11,121 late-stage oral cancer patients in the National Cancer Database from 2010 to 2016. We hypothesized that patient travel distance may affect treatment choices and impact outcome. We split travel distance (miles) into quartiles (D1-4) and assessed treatment choices, type of facility, and survival outcome in relation to distance traveled. Univariate and multivariate analyses addressed contributions of specific variables. White patients were most likely to travel farthest (D4) for treatment compared to Black patients (D1). Urban area patients traveled shorter distances than those from rural areas. Greater travel distance was associated with patients undergoing surgical-based therapies and treatment at academic centers. Patients in D1 had the lowest median survival of all distance quartiles. Surgery-based multimodality treatment (surgery and radiation) had a median survival significantly greater than for non-surgical therapy. Several factors including travel distance and treatment facility were associated with survival outcomes for late-stage oral cavity cancers. Consideration of these factors may help improve the outcome for this patient population.

References

Flanagin A, Frey T, Christiansen S . Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. JAMA. 2021; 326(7):621-627. DOI: 10.1001/jama.2021.13304. View

Luryi A, Chen M, Mehra S, Roman S, Sosa J, Judson B . Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2015; 141(7):593-8. DOI: 10.1001/jamaoto.2015.0719. View

Zanoni D, Montero P, Migliacci J, Shah J, Wong R, Ganly I . Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019; 90:115-121. PMC: 6417804. DOI: 10.1016/j.oraloncology.2019.02.001. View

Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M . Oral cancer: A multicenter study. Med Oral Patol Oral Cir Bucal. 2017; 23(1):e23-e29. PMC: 5822535. DOI: 10.4317/medoral.21999. View

Farquhar D, Masood M, Lenze N, McDaniel P, Mazul A, Sheth S . Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North Carolina. Oral Oncol. 2019; 89:115-120. PMC: 6369700. DOI: 10.1016/j.oraloncology.2018.12.029. View

Ho A, Kim S, Tighiouart M, Gudino C, Mita A, Scher K . Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer. JAMA Oncol. 2017; 4(7):985-989. PMC: 6584272. DOI: 10.1001/jamaoncol.2017.3852. View

da Silva Moro J, Maroneze M, Ardenghi T, Barin L, Cademartori Danesi C . Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein (Sao Paulo). 2018; 16(2):eAO4248. PMC: 5995547. DOI: 10.1590/S1679-45082018AO4248. View

Stitzenberg K, Sigurdson E, Egleston B, Starkey R, Meropol N . Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009; 27(28):4671-8. PMC: 3039919. DOI: 10.1200/JCO.2008.20.1715. View

Lee H, Roh J, Cho K, Choi S, Nam S, Kim S . Number of positive lymph nodes better predicts survival for oral cavity cancer. J Surg Oncol. 2019; 119(6):675-682. DOI: 10.1002/jso.25386. View

10.

Weng Y, Korte J . Racial disparities in being recommended to surgery for oral and oropharyngeal cancer in the United States. Community Dent Oral Epidemiol. 2011; 40(1):80-8. DOI: 10.1111/j.1600-0528.2011.00638.x. View

11.

Adrien J, Bertolus C, Gambotti L, Mallet A, Baujat B . Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors. Oral Oncol. 2013; 50(2):90-7. DOI: 10.1016/j.oraloncology.2013.10.016. View

12.

Vetterlein M, Loppenberg B, Karabon P, Dalela D, Jindal T, Sood A . Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017; 123(17):3241-3252. DOI: 10.1002/cncr.30744. View

13.

Pfister D, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel D . Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020; 18(7):873-898. DOI: 10.6004/jnccn.2020.0031. View

14.

Smith D, Murphy B . Lower levels of education and household income mediate lower dental care utilization among survivors of early life cancers. Prev Med Rep. 2019; 14:100868. PMC: 6475717. DOI: 10.1016/j.pmedr.2019.100868. View

15.

Osazuwa-Peters N, Adjei Boakye E, Hussaini A, Sujijantarat N, Ganesh R, Snider M . Characteristics and predictors of oral cancer knowledge in a predominantly African American community. PLoS One. 2017; 12(5):e0177787. PMC: 5435300. DOI: 10.1371/journal.pone.0177787. View

16.

Tassone P, Topf M, Dooley L, Galloway T, Biedermann G, Trendle M . Going Off Guidelines: An NCDB Analysis of Missed Adjuvant Therapy Among Surgically Treated Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2023; 168(6):1420-1432. PMC: 10948178. DOI: 10.1002/ohn.205. View

17.

Williams M . Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges. Curr Oncol Rep. 2016; 18(9):54. DOI: 10.1007/s11912-016-0540-y. View

18.

Brennan M, Treister N, Sollecito T, Schmidt B, Patton L, Yang Y . Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy. Head Neck. 2020; 43(1):164-172. PMC: 7756563. DOI: 10.1002/hed.26468. View

19.

Graboyes E, Ellis M, Li H, Kaczmar J, Sharma A, Lentsch E . Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018; 124(15):3181-3191. PMC: 6097948. DOI: 10.1002/cncr.31571. View

20.

Siegel R, Giaquinto A, Jemal A . Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. DOI: 10.3322/caac.21820. View